By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Atara Biotherapeutics 

2659 Townsgate Road
Suite 236
Thousand Oaks  California  91361  U.S.A.
Phone: 805-309-0888 Fax: n/a



Company News
Atara Biotherapeutics (ATRA) Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 5/11/2017 11:53:15 AM
Atara Biotherapeutics (ATRA) Enhances Commercial Expertise With The Appointment Of Dr. Derrell Porter To The Executive Leadership Team 5/10/2017 10:02:49 AM
Atara Biotherapeutics (ATRA) Announces First Quarter 2017 Financial Results And Recent Highlights 5/5/2017 11:39:15 AM
Atara Biotherapeutics (ATRA) Announces Positive Interim Results from Ongoing Phase I Trial of the Autologous Version of ATA188 in Patients with Primary and Secondary Progressive Multiple Sclerosis (MS) at the American Academy of Neurology Annual Meeting 2017 4/21/2017 8:54:50 AM
Atara Biotherapeutics (ATRA) Announces Collaboration With Merck & Co. (MRK) to Evaluate KEYTRUDA┬« (Pembrolizumab) In Combination With ATA129 In Nasopharyngeal Carcinoma (NPC) 4/21/2017 8:03:12 AM
Bay Area's Atara Biotherapeutics (ATRA) Leases Huge Space in SoCal 4/20/2017 5:49:34 AM
Atara Biotherapeutics (ATRA) Expands Management Team, Appoints Joe Newell As Executive Vice President, Chief Technical Operations Officer 4/3/2017 7:47:47 AM
Atara Biotherapeutics (ATRA)To Present At The Cowen and Company 36th Annual Health Care Conference 2/29/2016 7:53:05 AM
Atara Biotherapeutics (ATRA) To Present At The 34th Annual J.P. Morgan Healthcare Conference 1/5/2016 8:27:53 AM
Atara Biotherapeutics (ATRA) Stock Plunges as Company Stops Development of Kidney Drug PINTA 745 12/14/2015 6:28:19 AM